Patents by Inventor Sung-Seup Shin

Sung-Seup Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9131722
    Abstract: The present invention provides a pharmaceutical composition comprising the extract of hardy kiwifruit as an active ingredient in an effective amount to treat and prevent allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum and reducing the level of Th2 cytokines and IgE in serum. The present invention also provides a use of above extract for the preparation of pharmaceutical composition. The present invention also provides a health food or food additives, a cosmetic composition, a feed or feed additives comprising above extract for prevention or alleviation of allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum, and reducing the level of Th2 cytokines and IgE in serum.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: September 15, 2015
    Assignee: VIROMED CO., LTD.
    Inventors: Bong Cheol Kim, Mi Rim Jin, Eun Jin Park, Hyung Jin Jung, Sung Seup Shin, Jin Hwan Oh, Hwa Jun Lee, Sun Young Kim, Hyang Jeon
  • Patent number: 7074435
    Abstract: The present invention is related to pharmaceutical composition essentially comprising herbal extract of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Phlomidis Radix, Gentianae Radix, Clematidis Radix, and additionally comprising herbal extract selected from group consisting of Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Cinnamomi Cortex, Job's tear, Aurantii nobilis Pericapium, Ledebouriellae Radix, Lonicera japonica, Akebiae caulis, Caragana chamlagu, Licorice root, Notopterygium incisum, Persicae semen, Eucommia ulmoides, Atractylodes Rhizoma, Torilis japonica according to the need for the prevention and treatment of arthritic diseases and methods of using the above extracts and composition as potent anti-inflammatory and anti-arthritic agents.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: July 11, 2006
    Assignee: Pangenomics Co., Ltd.
    Inventors: Byung-Wook Cho, Mirim Jin, Hyung-Jin Jung, Sung-Seup Shin, Sunyoung Kim, Hyang Jeon, Jin-Hwan Oh, Hae-Kwan Eo, Bongcheol Kim
  • Publication number: 20040037909
    Abstract: The present invention provides a pharmaceutical composition comprising the extract of hardy kiwifruit as an active ingredient in an effective amount to treat and prevent allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum and reducing the level of Th2 cytokines and IgE in serum. The present invention also provides a use of above extract for the preparation of pharmaceutical composition. The present invention also provides a health food or food additives, a cosmetic composition, a feed or feed additives comprising above extract for prevention or alleviation of allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum, and reducing the level of Th2 cytokines and IgE in serum.
    Type: Application
    Filed: August 22, 2003
    Publication date: February 26, 2004
    Inventors: Bong Cheol Kim, Mi Rim Jin, Eun Jin Park, Hyung Jin Jung, Sung Seup Shin, Jin Hwan Oh, Hwa Jun Lee, Sun Young Kim, Hyang Jeon
  • Publication number: 20040001856
    Abstract: The present invention is related to pharmaceutical composition comprising an extract of Lentinus lepideus prepared by inventive preparation showing immune enhancing and immune modulating activity.
    Type: Application
    Filed: March 10, 2003
    Publication date: January 1, 2004
    Applicant: Pangenomics Co., Ltd.
    Inventors: Mirim Jin, Hyung-Jin Jung, Sung-Seup Shin, Hyang Jeon, Jeong-June Choi, Sunyoung Kim
  • Publication number: 20030143290
    Abstract: The present invention is related to pharmaceutical composition essentially comprising herbal extract of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Phlomidis Radix, Gentianae Radix, Clematidis Radix, and additionally comprising herbal extract selected from group consisting of Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Cinnamomi Cortex, Job's tear, Aurantii nobilis Pericapium, Ledebouriellae Radix, Lonicera japonica, Akebiae caulis, Caragana chamlagu, Licorice root, Notopterygium incisum, Persicae semen, Eucommia ulmoides, Atractylodes Rhizoma, Torilis japonica according to the need for the prevention and treatment of arthritic diseases and methods of using the above extracts and composition as potent anti-inflammatory and anti-arthritic agents.
    Type: Application
    Filed: January 16, 2003
    Publication date: July 31, 2003
    Applicant: Pangenomics Inc.
    Inventors: Byung-Wook Cho, Mirim Jin, Hyung-Jin Jung, Sung-Seup Shin, Sunyoung Kim, Hyang Jeon, Jin-Hwan Oh, Hae-Kwan Eo, Bongcheol Kim
  • Publication number: 20010019834
    Abstract: The present invention relates to chimeric proteins consisting of antigenic proteins of Helicobacter pylori and A2 and B subunits of Vibrio cholerae toxin, more specifically, to recombinant DNAs coding for antigenic proteins Helicobacter pylori and A2 and B subunits of Vibrio cholerae toxin, recombinant expression vectors containing the genes, a process for preparing the chimeric proteins employing the recombinant microorganisms transformed with the said expression vectors, and preventive and therapeutic vaccines comprising the chimeric proteins for Helicobacter pylori-associated diseases. The recombinant DNAs which are designed for convenient expression and gene manipulation, can express chimeric proteins having excellent immunogenicity to H. pylori, which are stable in stomach, and penetrate mucous membrane of intestines easily, finally to stimulate production of sIgA. Accordingly, the chimeric proteins expressed from the recombinant DNAs may be used as an active ingredient of the diagnostic kit for H.
    Type: Application
    Filed: September 27, 1999
    Publication date: September 6, 2001
    Inventors: BYUNG-O KIM, SUNG-SEUP SHIN, YOUNG-HYO YU, MYUNG-HWAN PARK, DEOK-JOON CHOI, HYUNG-JIN JUNG